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Myeloperoxidase (MPO) and human neutrophil lipocalin (HNL) are proteins which are stored in neutrophil
granulocytes, in the primary and secondary granules, respectively. These granules or their contents of MPO and
HNL are secreted upon activation of the cells, and measurement of these soluble markers in biological fluids, such
as bronchoalveolar lavage (BAL), has been proposed to mirror the degree of neutrophil activity in the tissue. We
conducted a BAL study in 10 healthy volunteers, with the aim to evaluate the intra-individual variability of the
concentration of HNL and MPO recovered in sequential aspirations, during a time period when the concentrations
of HNL and MPO in BAL fluids were considered to have equilibrated with those in the underlying tissues. The
concentrations of HNL were less variable than those of MPO (coecients of variability 0?33+0?07 vs. 0?92+0?28;
P+0?01). suggesting HNL to be a more useful marker of neutrophil activity within the airspace. The specificity of
HNL as a selective index of neutrophil cells was confirmed by means of immunohistochemical staining of
uninvolved lung tissue specimens obtained from patients referred to pulmonectomy due to carcinoma. While HNL
was located only to intracellular spaces of neutrophils, MPO was in addition located to other cells as well. We
speculate that the dynamic changes of pressure across the membranes and flow of solutes during a lavage process
might mobilize particulate matter and adherent cells, some of which may be loaded with MPO, and that this may
introduce larger variability in the recovery of MPO than of HNL. We conclude that using HNL as a soluble
indicator of neutrophil presence is more feasible than using MPO.
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The progress of several diseases of the lung has been
suggested to be governed by activated neutrophils (1–4),
and influx of neutrophils to the airways has been suggested
to be related to poor clinical outcome (5). The need of
feasible tools to make mechanistic studies and to predict the
outcome of progressive lung diseases is obvious. It is the
cellular activity, rather than the mere presence of cells that
may interfere with the pathophysiological events, and
analysation of the concentrations of various soluble
markers of inflammatory cells in local body fluids, mayReceived 15 November 1999 and accepted in revised form 20
December 1999.
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standing of various diseases of the lung.
Myeloperoxidase (MPO) and lactoferrin, which are
stored within the primary and secondary granules, respec-
tively, are known to be markers of neutrophil presence and
activity in circulating blood (6). Events in bronchial or lung
tissue involving inflammatory cells, may be mirrored by
soluble markers of these cells. These markers may be
recovered by bronchoalveolar lavage (BAL). Assessment of
lactoferrin in BAL fluid may, however, not be used as a
mere marker of neutrophil activity, since lactoferrin is also
produced by bronchial secretory cells (7). The search for a
specific index of neutrophil activity in BAL fluids has
previously favoured MPO (8). In a previous study on BAL
cells and lung tissue specimens, it was, however, observed
that a small fraction of lung macrophages had internalized
MPO, suggesting neutrophil phagocytosis by the macro-
phages (9). This may suggest a lack of specificity of MPO as
a marker of neutrophils in BAL fluids. Furthermore, there
was no interlobar consistency of MPO data, and a
considerable spread of the data on MPO in bronchial# 2000 HARCOURT PUBLISHERS LTD
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dierent lobes in healthy volunteers (10). These observa-
tions on MPO in BAL fluid may partially invalidate MPO
as the most relevant soluble marker of neutrophils in BAL-
fluid. Recently, another neutrophil product, human neu-
trophil lipocalin (HNL), was detected in the secondary
granulae population, and HNL was identified as a specific
marker located only in neutrophils, and no other tissue
(11).
The aim of the present study was to evaluate the
feasibility of using HNL as a soluble indicator of neutrophil
presence in the airways. The rate of transfer of various
solutes across lung membranes may be studied by
sequential lavage, and the rate of retrieval by lavage is
governed by factors, such as properties of the compounds
and of the lung membranes. Concentration to time curves
may be created and such curves for the retrieval of MPO
and HNL were made from data obtained by sequential
BAL performed in 10 healthy volunteers, in an attempt to
evaluate the feasibility of HNL in relation to that of MPO.
In a second experiment, the presence of HNL was assessed
by means of immunocytochemical staining methods, and
the localization of HNL within lung tissue specimens was
compared with that of MPO.
Materials and methods
SUBJECTS
Bronchoalveolar lavage was performed in 10 lifelong non-
smoking healthy volunteers (aged 23–54 years). Lung
function as assessed by forced expiratory volume in 1 sec
(FEV1) was 103+17% predicted normal value (12).
Biopsies from uninvolved bronchial and lung parenchymal
tissue were obtained from six patients referred to pulmo-
nectomy due to carcinoma. Informed consent was obtained
from patients and volunteers, and the study was approved
by the Ethical Research Committees of the Faculty of
Medicine, Universities of Lund and Uppsala, Sweden.
BRONCHOALVEOLAR LAVAGE
BAL samples were obtained after pre-medication of an
intramuscular injection of morphinescopolamine, and
lidocain (Xylocain, Astra, So¨derta¨lje, Sweden) which was
topically applied on the nasal and pharyngeal mucosa.
The fiberoptic bronchoscope (Olympus BF 1 T 10) was
introduced via the nasal pathway to the larynx and trachea,
and it was loosely positioned in an anterior segment of the
middle lobe. Bronchoalveolar lavage was performed by
instillation of 150 ml of tepid sterile saline and approxi-
mately 2 ml of the fluid was then sequentially aspirated
every 60 sec until 8 min after the instillation (13). The
aspirated specimens were collected in separate containers
kept on ice, and centrifuged at 200 g for 10 min at 48C. The
supernatants were then kept frozen at 7708C and assayed
for albumin (14), myeloperoxidase (MPO), and human
neutrophil lipocalin (HNL) using radioimmunoassays
(6,15).FIXATION AND RESIN EMBEDDING OF
LUNG TISSUE SPECIMENS
The biopsies were fixed either in methanol or in acetone,
pre-cooled to 208C. The fixative included the proteinase
inhibitors phenyl methyl sulphonyl fluoride (2 mM) and
iodoacetamide (20 mM) according to Britten et al. (16). The
samples were stored at 208C overnight and the samples
were then allowed to equilibrate to room temperature for
15 min in fresh fixative and subsequently transferred to
component A from the glycol methacrylate (GMA)
embedding kit (JBTM embedding Kit, Ted Pella, Inc,
Redding, CA, U.S.A.) to which 5% methyl benzoate had
been added. The infiltration was performed at 48C for 24 h.
The mixture of components A, B and C of the embedding
resin was poured into flat bottomed embedding moulds
(Leica, Wetzlar, Germany). The samples was placed into
moulds and the resin was polymerized at 48C. Specimen
blocks were stored at 7208C in air-tight plastic bags.
Sections with a thickness of 3 mm were cut with glass knifes
on an LKB Historange Microtube (LKB Instruments,
Bromma, Sweden). The section were then placed on




The sections were re-humidified with PBS and 0?2% BSA
prior to addition of the monoclonal primary antibody. The
samples were incubated with anti-HNL and anti-MPO at
room temperature in a humid chamber for 30 min. The
concentration of anti-HNL antibody was 0?02 mg ml71
and that of anti-MPO in antibody was 0?01 mg ml71.
Incubation was terminated by washing in PBS with 0?2%
BSA. The antigen-antibody complex was visualized by
using a commercial APAAP (alkaline phosphatase–anti-
alkaline phosphatase) kit with fast red substrate (K670,
Dako, Glostrup, Denmark). Instructions given in the
manual were carefully followed. Bound alkaline phospha-
tase resulted in a bright red colour identifying positively
stained cells. In negative controls the primary antibody was
omitted. The samples were then counterstained with
Mayer’s hematoxylin (Merck D 6071, Darmstadt, Ger-
many) for 6 min and observed with a Leica DRMB
microscope. Fuji 200 ASA film was used for the colour
prints.
STATISTICAL METHODS
Mean and standard deviations are given unless otherwise
stated. Student’s t-test for dependent or independent
samples was used for calculation of dierences by means
of a statistical package (Statistica for Windows, Statsoft,
Tulsa OK, U.S.A.) A probability value of 0?05 or less was
used to indicate statistical significance. Coecient of
variation (CV) was used as an index of variability and
defined as standard deviation divided by mean value.
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ASSAY OF HNL, MPO AND ALBUMIN IN
BAL-FLUID
Successive and time-dependent increases of the concentra-
tions of HNL, MPO and albumin were recorded during the
first 3 min after the bolus instillation of saline into the
airways (Fig. 1). While the recovery of albumin continued
to increase with increasing dwelltime, the concentrations of
MPO and HNL tended to level o after the first 3 min dwell
in the airways. During the last 4 min of the lavage, when the
concentration curves of HNL and MPO tended to reach a
plateau, the intra-individual variability of the concentra-
tions of HNL (0?33+0?07) was significantly lower than that
of MPO (0?92+0?28, P=0?01).
IMMUNOSTAINING OF LUNG TISSUE
SECTIONS WITH ANTI-HNL AND
ANTI-MPO
Fig. 2(a–f) shows the results of staining of lung tissue
sections with antibodies against HNL and MPO, respec-
tively. Anti-HNL stained brightly the present neutrophils,
but no other cells. In contrast, anti-MPO stained neutro-
phils as well as some additional cells, some of which may be
monocytes.
Discussion
Solutes recovered by BAL are transferred along concentra-
tion gradients and by osmotic forces. The lavage techniqueFIG. 1. Human neutrophil lipocalin (HNL, g l71; &),
myeleoperoxidase (MPO, g l71 *) and albumin
(mg l 71,~) in bronchoalveolar lavage fluid, sequentially
aspirated in 10 healthy volunteers. Dwelltime of the
lavage fluid within the airway lumen is indicated on the x-
axes, and concentrations of HNL, MPO or albumin are
indicated on the y-axes (mean and SEM are indicated).used in this study, employing bolus instillation of saline into
the airways, may result in a temporary local fluid overload
in the airspace, and outflow of water from the airway lumen
might occur to regain homeostasis (13). Such a process
would explain the rapid increase of the concentrations of
solutes recoverable by lavage before homeostasis is gained.
We recorded rapid initial increases of HNL, MPO and
albumin. As previously described (17), the concentration of
albumin increased with duration of lavage and in our
experiment, the concentration continued to increase in the
series of aliquots. The increase may suggest that albumin
continuously entered the airspace during the lavage process
presumably by osmotic forces from a large pool, consistent
with the interstitial tissue and/or plasma pool to be the
main source of albumin in BAL. Concentrations of
albumin, HNL or MPO were not measured in serum in
our healthy individuals in this study, and we postulate that
concentrations of these substances in serum were normal.
After having approached steady state level in BAL fluid, the
concentration of albumin was around 100 mg l71, which
corresponds to around 0?24% of circulating albumin
(reference value in serum is 42 g l71). The concentrations
of HNL and MPO tended to level o already after 3 min
dwelltime of saline within the airspace, and we interpret this
as attaining of a state of equilibrium. The concentrations in
BAL of HNL was then around 60 mg l71 and MPO was
around 20 mg l71. The fact that a state of equilibrium was
reached already within 3 min after introduction of saline
may suggest that a larger proportion of HNL and MPO
than of albumin originate from a local rather than a
systemic source, such as airway mucosa or adjacent tissue.
Furthermore the ratios of BAL to serum concentrations at
equilibrium of HNL or MPO were much higher than that
of albumin [reference values of HNL and MPO in serum
are 78 mg l71 (18) and 248 mg l71 (19) respectively]; 77%
and 8% respectively, and this may also suggest HNL and
MPO to originate from a local pool rather than the serum
pool.
We chose to study the variability of concentrations of
HNL and MPO during the state of equilibrium. Our results
clearly indicated that the spread of data on HNL was lower
than that of MPO in our healthy individuals, suggesting a
higher degree of reproducibility of data on HNL obtained
in BAL fluid. There are no major dierences in accuracy of
the methods for analysing MPO and HNL that could
explain the dierences in reproducibility. HNL is a neutral
and MPO is a basic protein, and it may be speculated that
the transfer of electrically charged proteins through the
bipolar alveolocapillary membrane, may dier depending
on dierences in biochemical properties, such as isoelectric
points. It is however, unclear whether such a dierence
might result in variable recovery of HNL and MPO by
BAL. The dynamic changes of pressure across lung
membranes as well as flow of solutes during a lavage
process might mobilize particulate matter and adherent
cells, some of which may be loaded with MPO. Such an
event might explain a variable recovery of MPO, since it
was shown, by means of immunohistochemical methods,
that HNL was exclusively located only in neutrophils in the
lung tissue specimens, and not in any other cell type, while
FIG. 2. Human neutrophil lipocalin (HNL, left panel)- and myeloperoxidase (MPO, right panel)- positive cells in 3 mm
sections cut from samples fixed in methanol at 7208C and embedded in glycol methacrylate. (a) Brightly stained HNL-
specific cells (neutrophils) in a capillary lumen. The immunocomplex was visualized by using APAAP with fast red substrate
(magnification6780). (b) MPO-positive cells in lung parenchyma (magnification6305). (c) HNL-positive cells in a blood
vessel (v) and a bronchiole (b) to the right (magnification679). (d) a similar place with brightly stained MPO-positive cells
(magnification6305). (e) HNL- and (f) MPO-positive cells in a large blood vessel in subsequent sections cut from a sample
from bronchial tissue. The number of HNL-positive cells was often lower than of the number of MPO-positive cells
(magnification679).
HUMAN NEUTROPHIL LIPOCALIN AND MYELOPEROXIDASE 567MPO was localized in neutrophils, but in addition also
found in other cells. These findings agree with previous
observations (9).
We conclude that HNL in BAL fluid seems to be a more
relevant index of neutrophil presence and secretory activityand that measurement of HNL in BAL fluid is more
reproducible and may be more specific for neutrophil
activity in airways than that of MPO. Furthermore, HNL,
in contrast to MPO, was located only in neutrophils in lung
tissue specimens.
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